PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15771957-5	2005	Thus, studies were initiated to evaluate the ability of depsipeptide to enhance the cytotoxic activity of Ad5-TRAIL against human prostate tumor cells.	Depsipeptides	56-68	Alzheimer disease, familial, type 5	Homo sapiens	106-109	
15771957-7	2005	Additionally, tumor cell killing by Ad5-TRAIL was higher following depsipeptide pretreatment.	Depsipeptides	67-79	Alzheimer disease, familial, type 5	Homo sapiens	36-39	
15771957-10	2005	These results indicate that depsipeptide is a potent agent for enhancing the activity of Ad5-TRAIL by multiple mechanisms, allowing for a more efficient use of Ad5-TRAIL as an antitumor therapy.	Depsipeptides	28-40	Alzheimer disease, familial, type 5	Homo sapiens	89-92	
15771957-10	2005	These results indicate that depsipeptide is a potent agent for enhancing the activity of Ad5-TRAIL by multiple mechanisms, allowing for a more efficient use of Ad5-TRAIL as an antitumor therapy.	Depsipeptides	28-40	Alzheimer disease, familial, type 5	Homo sapiens	160-163